Back to YC Companies
Ditto Biosciences
Winter 2026
Active
Evolutionary intelligence for autoimmune disease
4 people View on YC
Ditto Biosciences at a glance
- Y Combinator batch
- Winter 2026
- Status
- Active
- Industry
- Healthcare
- Team size
- 4 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Ditto Biosciences
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology. Viruses, ticks, and worms have experimented over millions of years to create proteins that control the human immune system. We use AI to identify these proteins and engineer them into next-generation autoimmune therapies. Our team is three PhD scientists from UCSF, UCSD, and UC Berkeley who have worked together for 3+ years in biotech. We have deep expertise in parasite biology, computational biology, and software for AI-based protein structure prediction